Tag: Food & Drug Administration
FDA Approves Aimovig to Prevent Migraines
Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo
FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures
Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure
FDA Approves Non-Opioid Treatment for Opioid Withdrawal
Lucemyra is an oral selective alpha 2-adrenergic receptor agonist
FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit
FDA Expands Use of MS Drug to Include Children
Gilenya is the first multiple sclerosis drug approved for children
FDA Targets Clinics Offering Unapproved Stem Cell Therapies
Clinics claim unapproved therapies can treat number of diseases and conditions, including ALS and cancer
FDA Permits Marketing of New Device for Treating GI Bleeding
Hemospray is an aerosolized spray that delivers a mineral blend to the bleeding site
FDA Approves Drug Combo for Aggressive Thyroid Cancer
Dabrafenib + trametinib approved to treat BRAF-positive anaplastic thyroid cancer
FDA Approves First Drug for Rare Form of Rickets
Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia
FDA Approves AI Device to Detect Diabetic Retinopathy
FDA permits marketing of novel artificial intelligence technology that can be used in primary care office
